VALN trades 73.2% below Wall Street's consensus target of $11.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes VALN achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 3 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, Valneva SE (VALN) has a Wall Street consensus price target of $11.00, based on estimates from 3 covering analysts. With the stock currently trading at $6.35, this represents a potential upside of +73.2%. The company has a market capitalization of $602M.
Analyst price targets range from a low of $11.00 to a high of $11.00, representing a 0% spread in expectations. The median target of $11.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, VALN trades at a trailing P/E of -4.2x. Analysts expect EPS to grow +46.1% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 NVAXNovavax, Inc. | $1.7B | $10.55 | $18.00 | +70.6% | Buy | — | 23 |
 DYAIDyadic International, Inc. | $15M | $0.41 | — | — | — | — | — |
 IBRXImmunityBio, Inc. | $9.0B | $8.63 | $12.00 | +39.0% | Buy | — | 5 |
 SIGASIGA Technologies, Inc. | $227M | $3.17 | — | — | Buy | 1.9x | 1 |
 PFEPfizer Inc. | $160.6B | $28.17 | $28.50 | +1.2% | Hold | 9.5x | 39 |
 MRKMerck & Co., Inc. | $365.8B | $148.11 | $158.12 | +6.8% | Buy | 53.9x | 38 |
 GSKGSK plc | $99.6B | $49.71 | $60.00 | +20.7% | Hold | 13.8x | 29 |
 SNYSanofi | $100.0B | $41.66 | $49.50 | +18.8% | Hold | 10.0x | 27 |
 BNTXBioNTech SE | $24.7B | $98.46 | $121.83 | +23.7% | Buy | — | 24 |
 MRNAModerna, Inc. | $72.3B | $182.11 | $115.70 | -36.5% | Hold | — | 29 |
Quick answers to the most common questions about buying VALN stock.
The consensus Wall Street price target for VALN is $11, representing 73.2% upside from the current price of $6.35. With 3 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
VALN has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $11 implies 73.2% upside from current levels.
VALN's current price is $6.35 with a consensus target of $11 (73.2% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $11 for VALN, while the most conservative target is $11. The consensus of $11 represents the median expectation. These targets typically reflect 12-month expectations.
VALN is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 0 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month VALN stock forecast based on 3 Wall Street analysts shows a consensus price target of $11, with estimates ranging from $11 (bear case) to $11 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on VALN, with a "Buy" consensus rating and $11 price target (73.2% upside). 2 of 3 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
VALN analyst price targets range from $11 to $11, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $11 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.